Peptide Advertising on Facebook — What Works in 2026

Peptide advertising on Facebook operates in the most ambiguous compliance space of any telehealth vertical. Peptides are not FDA-approved for most uses that telehealth brands promote. They exist in a regulatory gray zone where compounding pharmacies can prepare them, but brands cannot make medical efficacy claims. Meta knows this and treats peptide ads with extreme scrutiny. If your ad copy sounds like a supplement company selling research chemicals, your account will get banned. This guide explains what actually works after managing peptide ad accounts with combined spend over $5M.

Why Peptide Ads Get Rejected More Often Than Expected

Most peptides advertised by telehealth brands are not FDA-approved for human use in the conditions being promoted. BPC-157 is not approved for tissue repair. TB-500 is not approved for injury recovery. Ipamorelin is not approved for growth hormone release outside of specific medical conditions. That does not make them illegal, but it does mean you cannot advertise them as treatments.

Meta's review system flags peptide ads because the category has a history of unregulated research chemical sales and bodybuilding supplement marketing. The platform does not differentiate between legitimate compounding pharmacies and unlicensed peptide vendors unless your ad makes that distinction clear. Most peptide telehealth brands fail the first review because their ads make efficacy claims without proper medical framing.

What You Cannot Say in Peptide Facebook Ads

Do not make treatment claims. "BPC-157 heals gut inflammation" fails review. So does "TB-500 repairs torn ligaments." These are medical efficacy claims for compounds that are not FDA-approved for those uses. Meta treats them as unsubstantiated health claims, which violates advertising policies.

Do not reference athletic performance or bodybuilding. "Recover faster between workouts" or "optimize muscle repair" triggers rejection. Meta interprets these as performance enhancement claims, which fall into the same category as steroid advertising. Your ads must focus on physician-supervised peptide therapy, not athletic optimization.

Do not position peptides as alternatives to FDA-approved medications. You cannot say "BPC-157 works better than anti-inflammatories" or "Ipamorelin is safer than growth hormone injections." These comparisons imply medical equivalence that FDA and Meta do not recognize.

What Passes Review for Peptide Ads

Education-first framing. "Learn about peptide therapy for regenerative medicine" passes review more reliably than "get peptides for injury recovery." The first positions your service as educational. The second implies a treatment claim. Meta is more lenient on educational content than direct-response sales ads.

Physician-led content discussing peptide research. Ads featuring licensed doctors explaining what peptides are, how they work in clinical research, and what the consultation process involves pass review at a much higher rate than UGC or testimonial-style ads. The presence of a medical professional signals legitimacy.

Focus on access to compounded medications, not outcomes. "Get a prescription for compounded peptides from a licensed provider" is compliant. "Heal faster with peptide therapy" is not. The first describes the service. The second makes a medical claim that Meta does not allow for non-FDA-approved compounds.

How to Handle Specific Peptide Claims

BPC-157. Most BPC-157 telehealth ads get rejected because they make gut health or tissue repair claims. The compliant approach is to discuss BPC-157 as a research compound used in regenerative medicine under physician supervision. You cannot promise healing or repair outcomes.

TB-500. TB-500 ads that reference injury recovery or tissue regeneration fail review. The compliant framing is to position TB-500 as a peptide used in clinical settings for patients working with their doctors on recovery protocols. You describe the medical context, not the specific outcome.

Ipamorelin. Ipamorelin ads that promise growth hormone release or anti-aging benefits get rejected. The compliant approach is to discuss Ipamorelin as part of a physician-supervised hormone optimization protocol. You cannot claim it reverses aging or increases muscle mass.

The Creative Formats That Work for Peptide Brands

Doctor-led explainers on regenerative medicine. A licensed physician discussing the science of peptides, the research behind their use, and the consultation process. This format avoids all compliance tripwires while building credibility. The call-to-action should lead to more information or a consultation, not a direct peptide purchase.

Patient testimonials about the experience, not the results. A patient can say "my doctor recommended peptides as part of my recovery plan, and the telehealth consultation made it easy to get started." That describes the service. A patient cannot say "BPC-157 healed my gut issues in six weeks." The second is a treatment claim that Meta does not allow.

Educational content on compounding pharmacy regulations. Explain how compounded peptides differ from FDA-approved drugs. Clarify that peptides are prepared by licensed pharmacies under physician oversight. This framing demonstrates that you operate within medical regulations, not as a research chemical vendor.

What to Do If Your Peptide Ad Gets Rejected

Request manual review and provide documentation that your service operates under physician supervision with licensed compounding pharmacies. Include links to your medical licensing, pharmacy partnerships, and patient consultation process. Meta's automated system cannot distinguish between legitimate peptide telehealth and unregulated research chemical sales.

If the appeal fails, rewrite your ad to remove all outcome-based claims. Replace "heal faster" with "physician-supervised peptide therapy." Replace "recover from injury" with "regenerative medicine consultation." The outcome is implied, but you are not making a medical claim.

Test your ads on smaller audiences before scaling. Peptide ads have a higher rejection rate than other telehealth verticals, so launching at $50-100 per day allows you to confirm compliance before committing larger budgets.

How State Regulations Affect Peptide Advertising

Some states restrict or prohibit compounded peptide advertising. California, New York, and Texas have specific rules about what claims compounding pharmacies and telehealth providers can make. Meta enforces state-level regulations even when brands assume federal law is the only standard.

Before launching peptide ads, check the advertising regulations in your target states. If a state prohibits compounded peptide claims, you cannot advertise there even if your service is legal. Meta will enforce the stricter state rule and flag your ads as non-compliant.

The team has seen peptide ad accounts banned because the brand advertised in states with restrictive compounding laws. The appeal process failed because the brand could not prove compliance with state pharmacy regulations. Know your state rules before spending ad budget.

How to Build a Long-Term Peptide Advertising Strategy

Meta will continue tightening policies for peptide advertising as the category grows. The platform is under regulatory pressure to prevent unsubstantiated health claims, and peptides are a high-risk category. The brands that build compliance into their creative from day one will survive. The brands that treat peptides like supplements will lose their ad accounts.

Invest in physician credibility. Feature licensed doctors in your ads. Show the consultation process. Clarify that peptide therapy requires medical evaluation and prescription. These elements protect your account and improve patient trust.

Diversify your creative formats. Do not rely entirely on UGC or testimonial content. Physician-led videos, educational explainers, and patient journey storytelling create a portfolio of compliant creative that survives platform review. The brands that get banned usually run 5-10 aggressive UGC ads with outcome-based claims and no medical oversight signals.

The Difference Between Peptide Ads and Supplement Ads

Meta treats peptides as prescription medications, not supplements. That means you cannot advertise peptides using the same strategies you would use for creatine or protein powder. Supplement ads can make structure-function claims ("supports muscle recovery"). Peptide ads cannot, because peptides are compounded medications that require physician oversight.

If your peptide brand also sells supplements, run separate campaigns with separate creative. Do not mix peptide claims with supplement claims in the same ad. Meta's review system will flag the peptide content and reject the entire ad, even if the supplement portion is compliant.

For more on telehealth advertising compliance, see our guides on Meta ad policies, compounding pharmacy advertising, and FDA rules. If your account has been restricted, read how to get reinstated. More at our compliance hub.

Need peptide creative that passes Facebook review on first submission? We produce compliant video ads for longevity and regenerative medicine telehealth brands exclusively. Book a call.